| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0344-0338(99)80024-7 |
| P698 | PubMed publication ID | 10220791 |
| P2093 | author name string | Li Y | |
| Sarkar FH | |||
| Grignon DJ | |||
| Pontes JE | |||
| Wood DP Jr | |||
| Sakr W | |||
| Rakozy C | |||
| Gururajanna B | |||
| Gheiler E | |||
| P2860 | cites work | p53 in prostate cancer: frequent expressed transition mutations | Q36674878 |
| Cytoplasmically sequestered wild-type p53 protein in neuroblastoma is relocated to the nucleus by a C-terminal peptide | Q37088586 | ||
| Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate. | Q39377802 | ||
| Frequency of residual neoplasm in the prostate following three‐dimensional conformal radiotherapy | Q39377931 | ||
| Tumour suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage. | Q40422537 | ||
| Codon 72 polymorphism of the TP53 gene | Q40522948 | ||
| Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer | Q40856962 | ||
| Heat shock protein 84 forms a complex with mutant p53 protein predominantly within a cytoplasmic compartment of the cell | Q41190845 | ||
| Statistical aspects of prognostic factor studies in oncology | Q42388377 | ||
| Biopsy after External Beam Radiation Therapy for Adenocarcinoma of the Prostate: Correlation with Original Histological Grade and Current Prostate Specific Antigen Levels | Q43515599 | ||
| p53 immunohistochemical and genetic alterations are associated at high incidence with post-irradiated locally persistent prostate carcinoma | Q71072966 | ||
| Tumor suppressor p53 gene mutation in squamous cell carcinoma of the larynx | Q71673594 | ||
| Tumor suppressor gene p53 mutations in human prostate cancer | Q71854088 | ||
| p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610 | Q71980514 | ||
| Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group | Q72156114 | ||
| p53 oncogene mutations in human prostate cancer specimens | Q72663835 | ||
| p53 in tumour pathology: can we trust immunohistochemistry?--Revisited! | Q72730267 | ||
| P433 | issue | 3 | |
| P921 | main subject | immunohistochemistry | Q899285 |
| prostate cancer | Q181257 | ||
| P304 | page(s) | 129-135 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Pathology, Research and Practice | Q15758752 |
| P1476 | title | p53 gene alterations in prostate cancer after radiation failure and their association with clinical outcome: a molecular and immunohistochemical analysis | |
| P478 | volume | 195 |
| Q73269100 | Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinoma |
| Q75332721 | Expression of p21 cell cycle protein is an independent predictor of response to salvage radiotherapy after radical prostatectomy |
| Q35054043 | Immunopathological prognostic and predictive factors in prostate cancer |
| Q36849135 | Low-dose valproic acid enhances radiosensitivity of prostate cancer through acetylated p53-dependent modulation of mitochondrial membrane potential and apoptosis |
| Q33480331 | Molecular fingerprinting of radiation resistant tumors: can we apprehend and rehabilitate the suspects? |
| Q33276580 | Molecular staging of prostate cancer in the year 2007. |
| Q34245527 | Mutations within the tumour suppressor gene p53 are not confined to a late event in prostate cancer progression. a review of the evidence. |
| Q47634504 | Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study. |
| Q34563981 | Radiosensitization in prostate cancer: mechanisms and targets |
| Q77359704 | Relationship of p21(WAF-I) protein expression with prognosis in advanced prostate cancer treated by androgen ablation |
| Q35640632 | Salvage prostatectomy in patients who have failed radiation therapy or cryotherapy as primary treatment for prostate cancer |
| Q73443861 | Significance of p53 mutations in patients with chronic lymphocytic leukemia: a sequential study of 30 patients |
| Q33183543 | TP53 genotype but not p53 immunohistochemical result predicts response to preoperative short-term radiotherapy in rectal cancer |
| Q38063121 | The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review |
| Q37246446 | mRNA Expression Profiles for Prostate Cancer following Fractionated Irradiation Are Influenced by p53 Status |
| Q46740533 | p53 protein expression status and recurrence in men treated with radiation and androgen suppression therapy for higher-risk prostate cancer: a prospective phase II Cancer and Leukemia Group B Study (CALGB 9682). |
Search more.